HER2 Test

What the HER2 Test Means

The HER2 test is a laboratory test that measures how much HER2 protein is on cancer cells or how many copies of the HER2 gene are in the cancer’s DNA. HER2 stands for human epidermal growth factor receptor 2, a protein found on the surface of some cells that helps control normal cell growth and division. In healthy cells, HER2 helps regulate growth carefully. But in some cancers, especially breast cancer, cells make too much HER2. This extra HER2 can cause cancer cells to grow faster and spread more easily.

Why HER2 Testing Matters in Cancer Care

Knowing whether cancer cells have extra HER2 is important because it affects how the cancer behaves and how it might respond to treatment. Cancers with high HER2 levels are called HER2-positive. These cancers tend to grow more quickly and may be more aggressive. However, there are special treatments designed to target HER2. These targeted therapies can block the effects of HER2, helping to slow cancer growth or kill cancer cells. Doctors use HER2 test results to decide if these treatments might be helpful for a patient.

What Patients Might See or Hear About HER2

You might hear your healthcare team say your cancer is HER2-positive or HER2-negative. This means the test showed whether your cancer cells have more HER2 protein than usual. HER2 status is usually reported after a biopsy or surgery when the cancer tissue is examined. It can also come up when discussing treatment plans or clinical trials. Understanding your HER2 status helps your doctors recommend the best treatment options for you.

Where the HER2 Test May Appear

The term HER2 test or HER2/neu test may appear in your pathology report, treatment plan, or medical notes. It may also be mentioned in discussions about targeted therapies or clinical trials. Sometimes you may see other names for the same protein, like c-erbB-2 or human epidermal growth factor receptor 2. These all refer to the same HER2 protein.

What HER2 Test Results Do Not Automatically Mean

Having HER2-positive cancer does not automatically mean your cancer is more dangerous or that treatment will be the same for everyone. HER2 status is one factor among many that doctors consider when planning care. Not all cancers have high HER2 levels, so testing is necessary to understand each person’s unique situation. Also, a HER2 test alone does not provide a diagnosis or treatment plan—it is part of a larger picture.

Questions to Ask Your Care Team

If you hear about HER2 in your care, it can help to ask questions like: What does it mean that my cancer is HER2-positive? Are there treatments that target HER2? How will this affect my treatment plan and follow-up care? Your healthcare team can explain what your test results mean and how they influence your options.

Understanding HER2 in Context

Because HER2 can be called by different names, it’s helpful to recognize terms like HER2, HER2/neu, c-erbB-2, or human epidermal growth factor receptor 2 as referring to the same protein. When you see these terms, ask your care team how they apply to your specific cancer and treatment. Reading HER2 test results in context with other tests and your overall health is important for understanding your care.

Important Reminder

This information is educational and does not replace personalized medical advice. Each person’s cancer is unique, and treatment decisions depend on many factors. If you have questions about HER2 or how it relates to your care, talking openly with your healthcare team is the best next step. They can help you understand what your test results mean and guide you through your treatment choices.